GlassScriptPhysician profile
Thomas R Grant
NPI 1013997485
$1,625.40
in general payments reported to CMS, 2019-2025
31 companies · $446 in 2025
The $446 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $37.91 · 2021: $68.04 · 2022: $225 · 2023: $142 · 2024: $472 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,060.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,059.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $305.94 | 2022-2025 | Nucala, Trelegy Ellipta |
| Genzyme Corporation | $304.68 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $187.13 | 2019-2025 | Dupixent |
| Teleflex LLC | $116.23 | 2023-2025 | Urolift |
| Amgen INC. | $78.41 | 2023-2025 | Otezla, Repatha, Otezla |
| Aerin Medical INC. | $71.87 | 2019-2024 | |
| Smith+Nephew, INC. | $61.34 | 2022-2024 | Stravix |
| Intersect Ent, INC. | $45.53 | 2019-2020 | |
| Lilly USA, LLC | $32.95 | 2025 | Zepbound, Mounjaro |
| Abc Home Medical Supply, INC. | $29.58 | 2025 | |
| Medtronic USA, INC. | $27.76 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $24.62 | 2025 | Keytruda |
| Inspire Medical Systems, INC. | $23.81 | 2024 | Inspire |
| Optinose US, INC. | $23.31 | 2024 | |
| Astellas Pharma US INC | $22.03 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $21.04 | 2022 | |
| Phathom Pharmaceuticals, INC. | $19.80 | 2024 | Voquezna |
| Integra Lifesciences Corporation | $19.31 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Cochlear Americas | $19.22 | 2019 | |
| 180 Medical, INC. | $19.21 | 2019 | |
| Acclarent, INC | $18.25 | 2022 | |
| Bard Peripheral Vascular, INC. | $18.03 | 2025 | Model 200 Theraseed Palladium-103 In Readylink |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.99 | 2022 | |
| Tricoast Surgical Solutions LLC | $16.19 | 2025 | |
| Olympus America INC. | $16.02 | 2025 | Itind System |
| Greer Laboratories, INC. | $15.87 | 2019 | |
| Medtronic, INC. | $15.31 | 2022 | |
| Novo Nordisk INC | $14.96 | 2024 | |
| Stryker Corporation | $13.94 | 2025 | Audion Et Dilation System |
| Arbor Pharmaceuticals, INC. | $13.05 | 2019 | |
| Genentech USA, INC. | $13.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Grant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.